<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-147447" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Hydrazine Toxicology</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ivanov</surname>
            <given-names>Ivan</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lee</surname>
            <given-names>Vincent R.</given-names>
          </name>
          <aff>Northwell Health/Zucker School of Medicine at Hofstra School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ivan Ivanov declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vincent Lee declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>23</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-147447.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Hydrazines are a generic group of structurally related chemicals with numerous commercial uses. Different kinds of hydrazine compounds include hydrazines, hydrazones, 1,1-dimethylhydrazine, and 1,2-dimethylhydrazine. Most hydrazines are manufactured as an intermediate during agricultural chemicals and plastics production, a component of rocket propellant and fuels, water treatments, and a metabolite of the gyromitra mushroom and anti-tuberculosis drug isoniazid. Hydrazine exposure has toxic effects on multiple organ systems, including the neurological, hematological, pulmonary, dermatologic, and hepatic systems. Hydrazines produce a functional pyridoxine deficiency by inhibiting its synthesis by deactivating key coenzymes. Management involves aggressive supportive care and the administration of pyridoxine (vitamin B6) for refractory seizures. This activity reviews the history, potential for exposure, pathophysiology, evaluation, and management of hydrazine toxicity. The role of the interprofessional team in evaluating and managing patients exposed to this chemical compound is highlighted.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Understand the pathophysiology of hydrazine toxicity depending on the route of exposure and the system involved.</p></list-item><list-item><p>Recognize occupational and environmental risk factors commonly associated with exposure to hydrazine and its derivatives.</p></list-item><list-item><p>Implement effective diagnostic processes involving the interprofessional team.</p></list-item><list-item><p>Apply best practices to treat hydrazine toxicity, including decontamination, supportive care, and administration of pyridoxine for neurological sequelae.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=147447&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=147447">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-147447.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Hydrazines (R2N&#x02212;NR2)&#x000a0;are a class of chemical compounds with&#x000a0;2 nitrogen atoms linked by a single covalent bond and may carry up to four alkyl substituents.<xref ref-type="bibr" rid="article-147447.r1">[1]</xref><xref ref-type="bibr" rid="article-147447.r2">[2]</xref>&#x000a0;Organohydrazine compounds and their derivatives produce significant toxicity in human exposures.<xref ref-type="bibr" rid="article-147447.r3">[3]</xref></p>
        <p>Commonly encountered examples include hydrazine, hydrazones, 1,1-dimethylhydrazine, 1,2-dimethylhydrazine, and monomethylhydrazine (MMH). In its pure form, hydrazine (H2N-NH2) is a clear, colorless&#x000a0;liquid chemical with an ammonia-like&#x000a0;odor.<xref ref-type="bibr" rid="article-147447.r4">[4]</xref>&#x000a0;</p>
        <p>Throughout this activity, the&#x000a0;word "hydrazines" refers to&#x000a0;hydrazine, 1,1-dimethylhydrazine, 1,2-dimethylhydrazine, and monomethylhydrazine.</p>
      </sec>
      <sec id="article-147447.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Hydrazine and its derivatives have numerous industrial, military, and medical applications.<xref ref-type="bibr" rid="article-147447.r3">[3]</xref><xref ref-type="bibr" rid="article-147447.r5">[5]</xref>&#x000a0;Due to its high heat of combustion and highly exothermic reaction in the presence of oxygen, German scientists first developed hydrazine as the principal component of rocket fuel during World War II.<xref ref-type="bibr" rid="article-147447.r6">[6]</xref> Postwar, hydrazines became widely adopted as a powerful and reliable propellant with liquid properties like water.<xref ref-type="bibr" rid="article-147447.r7">[7]</xref> From the 1970s to today, they can be found in thruster fuel for spacecraft and as a propellant for missiles.</p>
        <p>Because hydrazines possess strong reducing properties, they are commonly used as a starting or intermediate reactant during the production of foaming or blowing agents for plastic production, agricultural products (plant-growth regulators, herbicides, fungicides, insecticides), and polymers.<xref ref-type="bibr" rid="article-147447.r8">[8]</xref>&#x000a0;It is also used as an oxygen scavenger to prevent corrosion in boiler water and water-heating systems.&#x000a0;</p>
        <p>Naturally occurring hydrazines are rare and can be found as mycotoxins in the Gyromitra and Agaricus species of mushrooms. The Gyromitra mushrooms contain the toxin gyromitrin (n-methyl-N-formyl hydrazone) and undergo hydrolysis to the principal toxic compound monomethylhydrazine (MMH), which is responsible for seizures in severe poisoning. Small amounts of hydrazine have been reported in tobacco; however, there have been no documented toxicities from human exposures.<xref ref-type="bibr" rid="article-147447.r9">[9]</xref></p>
      </sec>
      <sec id="article-147447.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Epidemiological studies of the consequences of exposure to hydrazine can be divided into acute and chronic exposures.</p>
        <p>
<bold>Acute Exposure</bold>
</p>
        <p>Acute exposures have been documented&#x000a0;since 1965 and&#x000a0;were primarily associated with military occupational exposures to hydrazine.</p>
        <p>Frierson et al. described&#x000a0;2 cases where young men were exposed to vapors of hydrazine mixed with unsymmetrical dimethyl hydrazine (UDMH). Both were treated with pyridoxine with rapid improvement of their symptoms.<xref ref-type="bibr" rid="article-147447.r10">[10]</xref><bold>&#x000a0;</bold></p>
        <p>Reid et al. described a young sailor who accidentally ingested liquid hydrazine while working in the ship&#x02019;s engine room.<xref ref-type="bibr" rid="article-147447.r11">[11]</xref>&#x000a0;Sotaniemi et al. 1971 described a fatal accidental exposure to a machine worker with chronic repeated exposures for six months.<xref ref-type="bibr" rid="article-147447.r12">[12]</xref><bold>&#x000a0;</bold></p>
        <p>Kirklin et al. described a case of a man exposed to a hydrazine industrial explosion and went into a coma that responded to pyridoxine.<xref ref-type="bibr" rid="article-147447.r13">[13]</xref>&#x000a0;</p>
        <p>Harati and Niakin describe a case of a young man who accidentally ingested a mouthful of liquid hydrazine.<xref ref-type="bibr" rid="article-147447.r14">[14]</xref>&#x000a0;</p>
        <p>Dhennin et al. described a chemical technician exposed to a UDMH industrial explosion.<xref ref-type="bibr" rid="article-147447.r15">[15]</xref>&#x000a0;Kao et al. 2007 described a case of a fighter jet technician who experienced hepatic injury after exposure to a hydrazine fuel leak.<xref ref-type="bibr" rid="article-147447.r16">[16]</xref><bold>&#x000a0;</bold></p>
        <p>Binyamin et al 2018 described a case of an aircraft technician who developed elevated&#x000a0;creatine phosphokinase (CPK) levels after exposure to hydrazine vapor.<bold>&#x000a0;</bold></p>
        <p>Dermal exposures are mostly linked to occupational injuries through the gold-plating industry, chicken feed additives, herbicides, or steam power plants.<xref ref-type="bibr" rid="article-147447.r17">[17]</xref><xref ref-type="bibr" rid="article-147447.r18">[18]</xref><xref ref-type="bibr" rid="article-147447.r19">[19]</xref></p>
        <p>
<bold>Chronic Exposure</bold>
</p>
        <p>Chronic exposures have been further studied in epidemiological studies for various reasons, but mainly to determine the carcinogenicity of hydrazine. Unfortunately, many epidemiological studies on hydrazine&#x000a0;were confounded&#x000a0;by concomitant exposure to other chemicals, making direct&#x000a0;correlations difficult.<xref ref-type="bibr" rid="article-147447.r20">[20]</xref><xref ref-type="bibr" rid="article-147447.r21">[21]</xref><xref ref-type="bibr" rid="article-147447.r22">[22]</xref><xref ref-type="bibr" rid="article-147447.r23">[23]</xref>&#x000a0;</p>
        <p>Wald et al. studied 427 men exposed to varying levels of hydrazine, among other chemicals, in a hydrazine manufacturing plant.<xref ref-type="bibr" rid="article-147447.r24">[24]</xref>&#x000a0;He concluded that the overall number of deaths in the hydrazine-exposed group was lower than expected, and mortality rates from lung and all types of cancer were similar to expected values.<xref ref-type="bibr" rid="article-147447.r24">[24]</xref>&#x000a0;Roe et al. had previously examined 423 of these same individuals in 1978. They also determined that occupational exposures to hydrazine were not significantly associated with a greatly increased cancer incidence.<xref ref-type="bibr" rid="article-147447.r25">[25]</xref>&#x000a0;</p>
        <p>Contassot et al. described 130 men exposed to hydrazine at various levels over six months. They showed a statistically significant higher incidence of cancer in the high-exposure group (&#x0003e;1 ppm), which was reduced when skin cancers were excluded.<xref ref-type="bibr" rid="article-147447.r26">[26]</xref><bold>&#x000a0;</bold>Morris et al. followed up with 95% of the workers initially evaluated by Wald et al. (1984) and Roe et al. (1978) 10 years after their initial evaluation.&#x000a0;They determined that there was also no all-cause mortality increase from occupational exposure to hydrazine.<xref ref-type="bibr" rid="article-147447.r27">[27]</xref>&#x000a0;</p>
        <p>Ritz et al. 2006 performed an epidemiological study of 6107 aerospace workers exposed to varying amounts of hydrazine for at least&#x000a0;2 years and showed an increased risk of lung cancer mortality, increased incidence of colon and rectal cancers, and a possible dose-response association with pancreatic cancer.&#x000a0;This study also had patients who developed leukemias, lymphomas, and kidney cancers; however, the numbers of exposed individuals were too small to show significance.<xref ref-type="bibr" rid="article-147447.r22">[22]</xref><bold>&#x000a0;</bold>Common criticisms of this study are that there were many other chemicals the workers may have been exposed to.<xref ref-type="bibr" rid="article-147447.r20">[20]</xref>&#x000a0;</p>
        <p>Zhao et al. 2005 examined the same group and found a higher incidence of lung cancers and melanoma with a possible higher incidence of esophageal cancer, stomach cancer, non-Hodgkin lymphoma, and leukemias; however, they concluded&#x000a0;that it was most likely&#x000a0;attributed to mineral oil exposure.&#x000a0;In addition, they found a higher incidence of kidney cancers, which they attributed to trichloroethylene exposure.<xref ref-type="bibr" rid="article-147447.r28">[28]</xref>&#x000a0;</p>
        <p>Krishnadasan et al. 2007 also evaluated the same cohort of aerospace workers and found a higher incidence of prostate cancer; however, they attributed it to trichloroethylene exposure.<xref ref-type="bibr" rid="article-147447.r23">[23]</xref></p>
        <p>The World Health Organization (WHO) in 1987 described populations with potentially high occupational exposures as workers at facilities producing hydrazine itself and/or its salts and derivatives, propulsion testing facilities, rocket launching sites, and locations where aircraft using hydrazine as an emergency fuel are assembled or refueled.<xref ref-type="bibr" rid="article-147447.r26">[26]</xref><bold>&#x000a0;</bold></p>
        <p>The Agency for Toxic Substances and Disease Registry (ATSDR) in 1997 stated that human exposures to hydrazine and 1,1-dimethylhydrazine occur mainly in the workplace or the vicinity of aerospace or industrial facilities or hazardous waste sites.</p>
      </sec>
      <sec id="article-147447.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Hydrazine's pathophysiology depends on the route of exposure and the system it affects.</p>
        <p>Inhalation exposure causes direct pulmonary injury due to the caustic nature of hydrazine and&#x000a0;may also lead to an increased incidence of lung cancer.<xref ref-type="bibr" rid="article-147447.r22">[22]</xref>&#x000a0;In animal studies, hydrazine inhalational injuries have been shown to cause pulmonary edema and localized bronchial mucosal damage.<xref ref-type="bibr" rid="article-147447.r29">[29]</xref>&#x000a0;Importantly, there have been reports of inhalation injury causing systemic effects such as neurotoxicity and hepatotoxicity.<xref ref-type="bibr" rid="article-147447.r30">[30]</xref></p>
        <p>The pathophysiology of dermatological injury of hydrazine toxicity is mostly&#x000a0;derived from animal studies and a few human case reports.&#x000a0;Hydrazine can cause contact dermatitis or caustic injury.<xref ref-type="bibr" rid="article-147447.r31">[31]</xref><xref ref-type="bibr" rid="article-147447.r17">[17]</xref><xref ref-type="bibr" rid="article-147447.r18">[18]</xref> This is due to hydrazine's strong&#x000a0;alkali properties and can cause liquefactive necrosis similar to other alkali-caustic burns.<xref ref-type="bibr" rid="article-147447.r29">[29]</xref><xref ref-type="bibr" rid="article-147447.r32">[32]</xref>&#x000a0;There are&#x000a0;2 cases of people developing systemic symptoms from dermal exposure, including neurotoxicity and hepatotoxicity; however, these were exposures to industrial explosions, so there was likely a combination of dermal and inhalational exposures.<xref ref-type="bibr" rid="article-147447.r13">[13]</xref><xref ref-type="bibr" rid="article-147447.r15">[15]</xref>&#x000a0;</p>
        <p>Ingested oral&#x000a0;exposure to hydrazines has the potential to&#x000a0;cause systemic symptoms, mostly&#x000a0;secondary to taking medications that have hydrazine as a metabolite.&#x000a0;Asymptomatic patients taking isoniazid (INH) at therapeutic doses (300 mg/day) for two weeks&#x000a0;showed elevated levels of hydrazine in their blood and plasma.<xref ref-type="bibr" rid="article-147447.r26">[26]</xref><xref ref-type="bibr" rid="article-147447.r33">[33]</xref>&#x000a0;There have also been acute oral exposures to hydrazine through ingestion of hydrazine-containing fuel, which&#x000a0;produced systemic symptoms including neurotoxicity, specifically seizures, loss of consciousness, altered mental status, agitation, nystagmus, and peripheral neuropathy.<xref ref-type="bibr" rid="article-147447.r11">[11]</xref><xref ref-type="bibr" rid="article-147447.r14">[14]</xref></p>
        <p>Hydrazine's&#x000a0;neurotoxicity occurs from&#x000a0;disrupting&#x000a0;the&#x000a0;equilibrium between gamma-aminobutyric acid (GABA) and glutamate (the human body's primary inhibitory and excitatory neurotransmitters, respectively). Through various mechanisms, hydrazine-containing compounds&#x000a0;inhibit pyridoxine (vitamin B6) and its downstream metabolite, pyridoxal 5' phosphate (P5P), the essential cofactor for glutamic acid decarboxylase and GABA synthesis, resulting in reduced GABA levels and subsequent clinical effects of seizures. Hydrazine metabolites are found in INH and gyromitrin mycotoxin (from the gyromitra mushroom species).</p>
        <p>Isoniazid toxicity stems from several mechanisms of its downstream metabolites. INH hydrazine, 1,1-dimethylhydrazine,&#x000a0;and hydrazones directly inhibit the enzyme pyridoxine phosphokinase by&#x000a0;complexing its essential cofactor, pyridoxine.<xref ref-type="bibr" rid="article-147447.r26">[26]</xref>&#x000a0;Thus, pyridoxine&#x000a0;cannot convert to P5P,&#x000a0;the&#x000a0;catalysis for&#x000a0;the&#x000a0;enzyme glutamic acid decarboxylase, in effect inhibiting the conversion of glutamate to&#x000a0;GABA.&#x000a0;INH hydrazines also directly bind with pyridoxal phosphate to form a hydrazone complex that is renally excreted. Through these mechanisms, hydrazine and its derivatives cause a functional&#x000a0;pyridoxine deficiency, resulting in the depletion of GABA and an&#x000a0;excess of&#x000a0;glutamate, leading to refractory seizures.<xref ref-type="bibr" rid="article-147447.r26">[26]</xref></p>
        <p>Additionally, in animal studies, hydrazine has been shown to affect the urea cycle by increasing the activity of argininosuccinase and inhibiting ornithine-ketoacid transaminase, leading to hyperammonemia which can contribute to its neurotoxicity.<xref ref-type="bibr" rid="article-147447.r34">[34]</xref><xref ref-type="bibr" rid="article-147447.r29">[29]</xref>&#x000a0;</p>
        <p>Secondary to these mechanisms, hydrazine-induced neurotoxicity can present as any of the following: twitching, hyperreflexia, clonic movements, restlessness, violent behavior, altered mental status, ataxia, paresthesias, lethargy, seizures, and coma.<xref ref-type="bibr" rid="article-147447.r32">[32]</xref>&#x000a0;</p>
        <p>Similarly, hydrazine's hepatotoxicity is mainly known from isoniazid toxicity. Hydrazines metabolized from isoniazid by direct hydrolyzation or metabolism by N-acetyltransferase type 2 to acetylhydrazine are oxidized by CYPE1 to reactive metabolites that induce oxidative stress and alter lipid metabolism, causing hepatotoxicity.<xref ref-type="bibr" rid="article-147447.r35">[35]</xref>&#x000a0;This leads to focal hepatic necrosis, cell degeneration, and fatty liver.<xref ref-type="bibr" rid="article-147447.r32">[32]</xref></p>
        <p>Gyromitrin compounds from the Gyromitra species of mushrooms are metabolized to monomethylhydrazine and inhibit the conversion of glutamate to GABA by similar mechanisms.<xref ref-type="bibr" rid="article-147447.r35">[35]</xref></p>
        <p>Hydrazine's hemotoxicity is known through in vitro studies with human red blood cells. This showed the development of hemolytic anemia, methemoglobinemia, and Heinz body formation.<xref ref-type="bibr" rid="article-147447.r29">[29]</xref>&#x000a0;It is hypothesized that hydrazine and its derivatives cause denaturing of hemoglobin, which destroys red blood cells.<xref ref-type="bibr" rid="article-147447.r29">[29]</xref></p>
      </sec>
      <sec id="article-147447.s6" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p>The toxicokinetics of hydrazines are not fully characterized and are largely unknown,&#x000a0;as there are no human studies evaluating exposures to hydrazine through inhalation, cutaneous, or oral routes. Animal studies on oral, inhalational, and dermal exposures&#x000a0;suggest that hydrazines are rapidly absorbed into the blood and readily distributed to tissues without preferential accumulation at any specific site.<xref ref-type="bibr" rid="article-147447.r3">[3]</xref>&#x000a0;</p>
        <p>Tissue levels of hydrazine and 1,1-dimethylhydrazine generally reach maximal values within 1 hour and are undetectable after 24 hours.&#x000a0;In vivo and in vitro studies&#x000a0;indicate that hydrazines are metabolized&#x000a0;through several enzymatic and nonenzymatic pathways.<xref ref-type="bibr" rid="article-147447.r36">[36]</xref>&#x000a0;Free radicals and carbonium ion intermediates formed during the hydrazine metabolism may be&#x000a0;associated&#x000a0;with the adverse health effects produced during exposures.<xref ref-type="bibr" rid="article-147447.r3">[3]</xref>&#x000a0;Limited&#x000a0;animal studies&#x000a0;suggest that hydrazine is excreted primarily in the urine and air exhalation.<xref ref-type="bibr" rid="article-147447.r37">[37]</xref>&#x000a0;</p>
        <p>
<bold>A. Absorption</bold>
</p>
        <p>There are no studies regarding human absorption after oral, inhalation, or dermal hydrazine exposure.</p>
        <p>
<bold>Oral Exposure</bold>
</p>
        <p>Of note, isoniazid (INH), an antituberculosis drug, is metabolized into hydrazine and its derivatives. Patients taking&#x000a0;INH were found to have elevated levels of hydrazine in their blood plasma.<xref ref-type="bibr" rid="article-147447.r33">[33]</xref>&#x000a0;A single animal study (Preece et al. 1992) examining oral absorption of hydrazine in rats suggests that at least 19 to 46% of administered oral dose (2.9 - 81 mg/kg)&#x000a0;is absorbed, based on excreted urine levels of hydrazine and its metabolites over 24 hours.&#x000a0;However, the actual amount of absorption&#x000a0;by the gastrointestinal tract is most likely higher, as 24 hours may have been too short of a period.&#x000a0;</p>
        <p>
<bold>Inhalational Exposure</bold>
</p>
        <p>A single animal study (Llewellyn et al. 1986) investigated the absorption of hydrazine in lungs where rats were exposed to 10 to 500 ppm of hydrazine for 1&#x000a0;hour.<xref ref-type="bibr" rid="article-147447.r3">[3]</xref> Based on the excreted urine levels of hydrazine and its metabolites at 48 hours, the absorption was suggested to be 8.4 to 29.5%.<xref ref-type="bibr" rid="article-147447.r3">[3]</xref> However, the actual absorption in the lungs may be higher, as a large portion of the administered dose may be retained in the body tissue or excreted by fecal or pulmonary routes.&#x000a0;</p>
        <p>
<bold>Dermal Exposure</bold>
</p>
        <p>Toxicokinetic studies on hydrazine dermal exposures are limited to&#x000a0;2 animal studies on dogs examining monomethylhydrazine (MMH) and 1,1-dimethylhydrazine (UDMH).<xref ref-type="bibr" rid="article-147447.r38">[38]</xref><xref ref-type="bibr" rid="article-147447.r39">[39]</xref> Graded doses of MMH and UDMH were administered to&#x000a0;a 300-cm area of the&#x000a0;dog's chest. MMH and UDMH&#x000a0;were detectable in the blood within 30 seconds of initial application, indicating&#x000a0;rapid absorption.<xref ref-type="bibr" rid="article-147447.r39">[39]</xref><xref ref-type="bibr" rid="article-147447.r38">[38]</xref> Peak levels of both MMH and UDMH were found 1 hour after initial exposure.<xref ref-type="bibr" rid="article-147447.r38">[38]</xref><xref ref-type="bibr" rid="article-147447.r39">[39]</xref>&#x000a0;</p>
        <p>Of note, MMH was found to cause a reddish discoloration of the skin within 5 minutes of application, which progressed to purple and light grey and was associated with swelling.<xref ref-type="bibr" rid="article-147447.r39">[39]</xref> As opposed to UDMH, which caused a slight initial reddening of the skin that quickly dissipated and no visible local skin damage.<xref ref-type="bibr" rid="article-147447.r38">[38]</xref><xref ref-type="bibr" rid="article-147447.r39">[39]</xref></p>
        <p>
<bold>B. Distribution</bold>
</p>
        <p>There are no studies regarding&#x000a0;the distribution of hydrazine&#x000a0;in humans after oral, inhalation, or dermal exposures. Furthermore, no current studies are available regarding the distribution of hydrazine in animals after inhalation or dermal exposures.</p>
        <p>
<bold>Oral Exposure</bold>
</p>
        <p>A single animal study examines the&#x000a0;distribution and metabolism of ingested hydrazine in rats. After a single dose of 2.9-81 mg/kg hydrazine, peak plasma and liver hydrazine levels occurred at 30 minutes.<xref ref-type="bibr" rid="article-147447.r36">[36]</xref>&#x000a0;The authors found that liver concentrations of hydrazine did not increase proportionally with higher doses, suggesting saturation.<xref ref-type="bibr" rid="article-147447.r36">[36]</xref></p>
        <p>
<bold>C. Metabolism</bold>
</p>
        <p>Hydrazine is metabolized through several enzymatic and nonenzymatic pathways. However,&#x000a0;studies show that the&#x000a0;pathways involved and metabolites formed during the metabolism of hydrazines&#x000a0;are&#x000a0;not dependent on the route of exposure.&#x000a0;</p>
        <p>Metabolism of INH&#x000a0;occurs by either&#x000a0;direct hydrolysis of INH or by hydrolysis of its metabolite, acetylhydrazine.<xref ref-type="bibr" rid="article-147447.r33">[33]</xref> Slow acetylators were found to have higher plasma concentrations of hydrazine than fast acetylators after chronic dosing but not after a single dose.&#x000a0;Animal studies by Llewellyn et al. suggest that hydrazine undergoes acetylation to acetyl hydrazine and diacetyl hydrazine, then excreted in the urine.<xref ref-type="bibr" rid="article-147447.r40">[40]</xref> In addition, animal studies show that hydrazine is rapidly metabolized by cytochrome P-450 but also forms free radicals, which may be an important mechanism of hydrazine toxicity.<xref ref-type="bibr" rid="article-147447.r41">[41]</xref><xref ref-type="bibr" rid="article-147447.r40">[40]</xref></p>
        <p>
<bold>D. Excretion</bold>
</p>
        <p>No studies have been reported on human excretion after oral, inhalation, or dermal exposure to hydrazines.</p>
        <p>
<bold>Oral Exposure</bold>
</p>
        <p>A single animal study by Preece et al. found that at least 19 to 46% of the hydrazine administered was found in the urine of rats.<xref ref-type="bibr" rid="article-147447.r3">[3]</xref>&#x000a0;Additionally, hydrazine has also been detected in the urine of patients receiving INH.<xref ref-type="bibr" rid="article-147447.r33">[33]</xref>&#x000a0;</p>
        <p>
<bold>Inhalation Exposure</bold>
</p>
        <p>Unchanged hydrazine, acetyl hydrazine, and diacetyl hydrazine were recovered in the urine of rats inhaling hydrazine after 48 hours from administration.<xref ref-type="bibr" rid="article-147447.r3">[3]</xref>&#x000a0;(Llewellyn et al. 1986)&#x000a0;&#x000a0;</p>
        <p>
<bold>Dermal Exposure</bold>
</p>
        <p>The animal studies performed by Smith and Clark et al. on dermal exposure of hydrazine and 1,1-dimethylhydrazine reported detection in the urine at about 3 and 5 hours, respectively.<xref ref-type="bibr" rid="article-147447.r38">[38]</xref><xref ref-type="bibr" rid="article-147447.r39">[39]</xref></p>
      </sec>
      <sec id="article-147447.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>To recognize hydrazine toxicity, it is essential to&#x000a0;be familiar with&#x000a0;occupational and environmental risk factors known to be commonly exposed to hydrazine and its derivatives. The occupations most&#x000a0;commonly exposed to hydrazine are facilities producing or storing rocket fuels, such as propulsion testing facilities, rocket launching sites, aerospace facilities, hazardous waste sites, and military installations.<xref ref-type="bibr" rid="article-147447.r26">[26]</xref>&#x000a0;</p>
        <p>A medical history of concurrent tuberculosis may include&#x000a0;isoniazid (INH), which metabolizes into hydrazine. Mushroom foragers may be exposed to the&#x000a0;false morel, Gyromitra, which contains the mycotoxin gyromitrin that metabolizes into monomethylhydrazine (MMH).</p>
        <p>Hydrazine toxicity can occur through inhalation&#x000a0;and oral and dermal exposures. Exposures&#x000a0;may&#x000a0;be categorized as acute (&#x0003c;14 days), intermediate (15&#x000a0;to 364 days), and chronic (&#x0003e;365 days).<xref ref-type="bibr" rid="article-147447.r26">[26]</xref>&#x000a0;Chronic exposure to hydrazine can lead to similar symptoms&#x000a0;in the acute setting&#x000a0;but&#x000a0;also includes additional carcinogenic risk.<xref ref-type="bibr" rid="article-147447.r22">[22]</xref><xref ref-type="bibr" rid="article-147447.r25">[25]</xref><xref ref-type="bibr" rid="article-147447.r24">[24]</xref>&#x000a0;Hydrazine has been associated with various cancers, including lung, lymphopoietic, liver, colorectal, and skin cancers.<xref ref-type="bibr" rid="article-147447.r26">[26]</xref></p>
        <p>Dermal exposure has been mostly linked to occupational injuries through the gold-plating industry, chicken feed additives, herbicides, or steam power plants. <xref ref-type="bibr" rid="article-147447.r17">[17]</xref><xref ref-type="bibr" rid="article-147447.r18">[18]</xref><xref ref-type="bibr" rid="article-147447.r19">[19]</xref>&#x000a0;Skin irritation and caustic liquefactive necrosis may occur within 1 hour.&#x000a0;Hydrazine sulfate has&#x000a0;been reported to cause contact dermatitis,&#x000a0;suggesting&#x000a0;it is a sensitizing agent.<xref ref-type="bibr" rid="article-147447.r29">[29]</xref><xref ref-type="bibr" rid="article-147447.r42">[42]</xref><xref ref-type="bibr" rid="article-147447.r43">[43]</xref><xref ref-type="bibr" rid="article-147447.r18">[18]</xref><xref ref-type="bibr" rid="article-147447.r17">[17]</xref>&#x000a0;Chronic dermal exposure by a factory worker in a steam power station has also been linked to the development of multiple basal cell carcinomas in a case report.<xref ref-type="bibr" rid="article-147447.r19">[19]</xref>&#x000a0;</p>
        <p>Acute inhalational hydrazine exposure has been associated with pulmonary edema and pleural effusions.<xref ref-type="bibr" rid="article-147447.r29">[29]</xref>&#x000a0;Exposed individuals to hydrazine and 1,1-dimethylhydrazine vapors exhibited symptoms of&#x000a0;dyspnea, sore throat, burning sensation of the face and nasal mucosa, and chest tightness.<xref ref-type="bibr" rid="article-147447.r29">[29]</xref>&#x000a0;This may&#x000a0;progress&#x000a0;to delayed pulmonary edema&#x000a0;with pleural effusions and death. Hydrazine has also been associated with an ammonia-like odor.<xref ref-type="bibr" rid="article-147447.r32">[32]</xref><bold>&#x000a0;</bold>Respiratory arrest in toxic inhalational exposures may be more attributed to hydrazine's neurotoxic and convulsive effects.&#x000a0;</p>
        <p>Neurotoxicity from acute exposures to hydrazine, monomethylhydrazine (MMH), and 1,1-dimethylhydrazine (UDMH) may range from&#x000a0;central nervous system (CNS)&#x000a0;depression&#x000a0;to seizures.<xref ref-type="bibr" rid="article-147447.r11">[11]</xref>&#x000a0;Hydrazine has been found to induce seizures at high doses but&#x000a0;CNS depression at low doses. The CNS depression described in human exposures has been reported to last up to 3 days.&#x000a0;In contrast, the alkyl derivatives of hydrazine, MMH, and UDMH induce primarily neuroexcitatory effects and tonic-clonic seizures, with MMH being more potent than UDMH. Other neuroexcitatory effects include twitching, hyperreflexia, and clonus.<xref ref-type="bibr" rid="article-147447.r29">[29]</xref></p>
        <p>Hydrazine and its derivatives may cause hemolytic anemia and methemoglobinemia.&#x000a0;MMH has been described as having the most severe hemotoxic effects.<xref ref-type="bibr" rid="article-147447.r29">[29]</xref>&#x000a0;</p>
        <p>Hydrazine exposure has been shown to cause an elevation in alanine aminotransferase (ALT) and aspartate aminotransferase (AST) within 5 hours and lasting up to 1 week, with resolution after 4 to 5 weeks.<xref ref-type="bibr" rid="article-147447.r4">[4]</xref>&#x000a0;Focal hepatic necrosis and fatty liver degeneration have been described in chronic exposures.<xref ref-type="bibr" rid="article-147447.r44">[44]</xref><xref ref-type="bibr" rid="article-147447.r45">[45]</xref>&#x000a0;In humans, there has been a case of an inhalation injury of a machinist&#x000a0;exposed to&#x000a0;hydrazine hydrate&#x000a0;once a week for&#x000a0;6 months, which proved fatal; the patient presented with hepatorenal failure and died&#x000a0;secondary to complications from pneumonia.<xref ref-type="bibr" rid="article-147447.r12">[12]</xref>&#x000a0;An aircraft technician also had an acute inhalation exposure (&#x0003c;10 minutes) that caused transient hepatotoxicity.<xref ref-type="bibr" rid="article-147447.r16">[16]</xref>&#x000a0;</p>
        <p>Chronic exposure to hydrazine can lead to similar symptoms&#x000a0;in the acute setting&#x000a0;but&#x000a0;also includes additional carcinogenic risk.<xref ref-type="bibr" rid="article-147447.r22">[22]</xref><xref ref-type="bibr" rid="article-147447.r25">[25]</xref><xref ref-type="bibr" rid="article-147447.r24">[24]</xref>&#x000a0;A study of chronic inhalation exposure to hydrazine in aerospace workers also&#x000a0;showed an increased risk of lung cancer mortality.<xref ref-type="bibr" rid="article-147447.r22">[22]</xref>&#x000a0;Prior studies with intermediate-to-chronic inhalation injury in a hydrazine-manufacturing plant did not show a statistically significant increase in lung cancer mortality due to the small sample sizes.<xref ref-type="bibr" rid="article-147447.r24">[24]</xref><xref ref-type="bibr" rid="article-147447.r21">[21]</xref>&#x000a0;Hydrazine has been associated with various cancers, including lung, lymphopoietic, liver, colorectal, and skin cancers.<xref ref-type="bibr" rid="article-147447.r26">[26]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-147447.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Oral ingestions of hydrazine may cause caustic injury and liquefactive necrosis due to its alkali properties.<xref ref-type="bibr" rid="article-147447.r14">[14]</xref><xref ref-type="bibr" rid="article-147447.r11">[11]</xref>&#x000a0;If the patient exhibits&#x000a0;any 2 of these 3 symptoms&#x02014;drooling, stridor, or vomiting&#x02014;the patient should be evaluated&#x000a0;by endoscopy to assess the extent of the esophageal and gastric injury.<xref ref-type="bibr" rid="article-147447.r46">[46]</xref>&#x000a0;Airway protection may be needed if there is extensive edema and caustic injury to the oropharynx and the inability to tolerate secretions.&#x000a0;</p>
        <p>The patient's mental status may&#x000a0;range from&#x000a0;CNS depression to CNS excitation, and seizures refractory to standard treatment with benzodiazepines, barbituates, and propofol may occur. Fingerstick blood glucose level should be obtained as hydrazine&#x000a0;is associated with hypoglycemia.<xref ref-type="bibr" rid="article-147447.r47">[47]</xref>&#x000a0;</p>
        <p>The pulmonary exam and chest radiography may&#x000a0;show signs of pleural effusion to pulmonary edema.&#x000a0;Blood gas oximetry may show&#x000a0;methemoglobinemia.&#x000a0;A complete blood count may show hemolytic anemia, and a blood&#x000a0;smear may show Heinz bodies.<xref ref-type="bibr" rid="article-147447.r29">[29]</xref>&#x000a0;The basic metabolic panel may show rhabdomyolysis and liver function testing may&#x000a0;range from transient transaminitis to fulminant hepatic failure.<xref ref-type="bibr" rid="article-147447.r45">[45]</xref>&#x000a0;Prolonged hepatic injury has been seen to last up to 1 week and resolves in&#x000a0;patients surviving the initial exposure&#x000a0;after 4&#x000a0;or 5 weeks.<xref ref-type="bibr" rid="article-147447.r16">[16]</xref></p>
        <p>Chronic exposures to hydrazine in the occupational setting should also be evaluated for certain cancers, as hydrazine is carcinogenic. Cancers&#x000a0;of the&#x000a0;colon, skin, nasal epithelium, lung, and liver have all been described but may be confounded due to exposures to other toxins in these studies.<xref ref-type="bibr" rid="article-147447.r48">[48]</xref><xref ref-type="bibr" rid="article-147447.r22">[22]</xref>&#x000a0;Hydrazine exposure has also been associated with basal cell carcinoma.<xref ref-type="bibr" rid="article-147447.r19">[19]</xref></p>
      </sec>
      <sec id="article-147447.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of hydrazine exposures involves decontamination, supportive care, and administration of pyridoxine for neurological sequelae, especially seizures. Patients should be removed from the site of exposure to a minimum of 75 feet away.&#x000a0;Full decontamination, including removing all clothing and copious irrigation of exposed skin and/or eyes with water&#x000a0;for a minimum of 15 minutes.<xref ref-type="bibr" rid="article-147447.r29">[29]</xref>&#x000a0;</p>
        <p>First responders and emergency medical services at the site of hydrazine exposure should wear Level A personal protective equipment against vapors, skin, and eyes. Caustic burns to the skin should be treated similarly to soft tissue injuries and may require special management at a burn center.<xref ref-type="bibr" rid="article-147447.r13">[13]</xref></p>
        <p>Inhalational exposures to hydrazine are managed by supportive care, including supplemental oxygen and close airway observation. Delayed pulmonary edema may occur, and observation for 24&#x000a0;to 48 hours may be required.&#x000a0;</p>
        <p>Oral ingestions of hydrazines may cause caustic injury to the upper airway and gastrointestinal tract; thus,&#x000a0;activated charcoal is not recommended in this situation. Since hydrazines are rapidly absorbed when ingested, activated charcoal administered after arrival to the emergency department may be futile. Early activated charcoal decontamination is recommended for acute isoniazid and gyromitra ingestions.<xref ref-type="bibr" rid="article-147447.r35">[35]</xref></p>
        <p>Hydrazine neurotoxicity, ranging from coma and seizures, has been treated successfully with pyridoxine.<xref ref-type="bibr" rid="article-147447.r13">[13]</xref><xref ref-type="bibr" rid="article-147447.r49">[49]</xref>&#x000a0;In INH-induced seizures, adults are given 1 g of IV pyridoxine for each gram of INH ingested, with a maximum dose of 5 g. If the amount ingested is unknown, 5&#x000a0;g of IV pyridoxine may be given empirically. Pediatric dosing is 70 mg/kg of IV pyridoxine with a maximum of 5&#x000a0;g.<xref ref-type="bibr" rid="article-147447.r35">[35]</xref><xref ref-type="bibr" rid="article-147447.r50">[50]</xref></p>
        <p>For the actively seizing patient, pyridoxine may be given 0.5 g/min until the cessation of seizure or the maximum dose is reached. After seizure control, the remainder of the dose may be infused over 4&#x000a0;to 6 hours to maintain pyridoxine concentrations while INH is eliminated.<xref ref-type="bibr" rid="article-147447.r50">[50]</xref> Repeat dosing is indicated if the patient&#x000a0;has CNS depression or non-convulsive status epileptics.&#x000a0;For hydrazine, MMH, and UDMH poisonings, using the same dosage as INH poisoning is reasonable. The dosing of pyridoxine&#x000a0;for hydrazine toxicity has varied from 200 mg intravenous with 400 mg intramuscular to 10 grams intravenously.<xref ref-type="bibr" rid="article-147447.r13">[13]</xref><xref ref-type="bibr" rid="article-147447.r51">[51]</xref>&#x000a0;Benzodiazepines and barbituates should also be used to stop seizure activity rapidly.</p>
        <p>Methemoglobinemia should be treated with standard treatment with methylene blue.</p>
      </sec>
      <sec id="article-147447.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>
<bold>Pulmonary Irritants</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Phosgene</p>
          </list-item>
          <list-item>
            <p>Chlorine</p>
          </list-item>
          <list-item>
            <p>Ammonia</p>
          </list-item>
          <list-item>
            <p>Ethylene oxide</p>
          </list-item>
          <list-item>
            <p>Chloramine</p>
          </list-item>
        </list>
        <p>
<bold>Hepatotoxicity</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Amantia mushrooms</p>
          </list-item>
        </list>
        <p>
<bold>Alkali Caustic Burns</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Sodium hydroxide</p>
          </list-item>
          <list-item>
            <p>Potassium hydroxide</p>
          </list-item>
          <list-item>
            <p>Sodium hypochlorite</p>
          </list-item>
          <list-item>
            <p>Ammonia</p>
          </list-item>
        </list>
        <p>
<bold>Seizures</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Status epilepticus of unknown origin</p>
          </list-item>
          <list-item>
            <p>Severe hyponatremia</p>
          </list-item>
          <list-item>
            <p>Substance-induced</p>
          </list-item>
          <list-item>
            <p>Sedative-hypnotic withdrawal</p>
          </list-item>
          <list-item>
            <p>Hypoxic syncope</p>
          </list-item>
          <list-item>
            <p>Anti-NMDA receptor encephalitis</p>
          </list-item>
        </list>
        <p>
<bold>CNS Depression/Coma</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Sedative-hypnotic intoxication</p>
          </list-item>
          <list-item>
            <p>Opioid intoxication</p>
          </list-item>
          <list-item>
            <p>Hepatic encephalopathy&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Hypoglycemia</p>
          </list-item>
          <list-item>
            <p>Cerebrovascular accident</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-147447.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis for hydrazine toxicity depends on the dose and route of exposure. There have only been&#x000a0;2 reported cases of death from direct hydrazine toxicity.<xref ref-type="bibr" rid="article-147447.r45">[45]</xref><xref ref-type="bibr" rid="article-147447.r12">[12]</xref> Most exposure cases show rapid improvement in neurologic symptoms and eventual improvement of hepatic injury.<xref ref-type="bibr" rid="article-147447.r29">[29]</xref><bold>&#x000a0;</bold>There have been cases of persistent neuropathy and&#x000a0;hepatic injury.<xref ref-type="bibr" rid="article-147447.r15">[15]</xref>&#x000a0;This excludes the prognosis of isoniazid or other medications with hydrazine metabolites.</p>
      </sec>
      <sec id="article-147447.s12" sec-type="Complications">
        <title>Complications</title>
        <p><bold>Pulmonary toxicity:</bold>&#x000a0;Mucosal irritation, pleural effusion, delayed pulmonary edema</p>
        <p><bold>Neurotoxicity:</bold>&#x000a0;CNS depression, coma, clonus, refractory seizures</p>
        <p><bold>Cutaneous toxicity: </bold>Dermatitis<bold>&#x000a0;</bold>and liquefactive necrosis</p>
        <p><bold>Hepatoxicity: </bold>Fulminant hepatic failure<xref ref-type="bibr" rid="article-147447.r29">[29]</xref></p>
        <p><bold>Nephrotoxicity</bold>: Rhabdomyolysis<xref ref-type="bibr" rid="article-147447.r45">[45]</xref></p>
        <p><bold>Hemotoxicity:</bold> Methemoglobinemia and hemolytic anemia</p>
        <p>Possible long-term sequelae are secondary to the potential carcinogenic nature of hydrazine exposure. These include lung, lymphopoietic, skin, colorectal, and liver cancers.<xref ref-type="bibr" rid="article-147447.r22">[22]</xref><xref ref-type="bibr" rid="article-147447.r48">[48]</xref><xref ref-type="bibr" rid="article-147447.r19">[19]</xref></p>
      </sec>
      <sec id="article-147447.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>Please consider consulting your poison control center for advice on managing hydrazine toxicity. Depending on the patient&#x02019;s status, consider consulting an intensivist, general surgery, or burn specialist, a gastroenterologist, and a nephrologist.</p>
      </sec>
      <sec id="article-147447.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>To avoid hydrazine toxicity, those potentially exposed to it through manufacturing or the military should be aware of the recommended exposure guidelines. The National Institute of Occupational Health and Safety (NIOSH) has set out certain Acute Exposure Guideline Levels for Hazardous Substances. The guideline level for the airborne concentration for which the general population is expected to experience discomfort or irritation for hydrazine is 0.1 ppm. The guideline level for the airborne concentration for which the general population is expected to experience long-lasting effects is 1.6 ppm in 8 hours.</p>
        <p>The guideline level for the airborne concentration for which the general population is expected to experience life-threatening health effects or death is 4.4 ppm in 8 hours. Overall, the NIOSH exposure limit is 0.03 ppm with a 2-hour ceiling. The odor threshold for hydrazine&#x02019;s ammonia-like odor is 3&#x000a0;to 4 ppm. There are also guidelines from the Occupational Safety and Health Administration, American Conference of Governmental Industrial Hygienists, and Short-Term Public Emergency Guidance Level. Those exposed to hydrazine should also be educated about the possible symptoms that acute exposure may cause.<xref ref-type="bibr" rid="article-147447.r26">[26]</xref></p>
      </sec>
      <sec id="article-147447.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Hydrazine exposure is commonly seen in occupations involving the handling, production, and use of rocket&#x000a0;fuel. Patients treated for tuberculosis and presenting with refractory seizures strongly suggest isoniazid overdose. Decontamination and good supportive care will manage most cases of hydrazine exposures.</p>
        <p>Respiratory arrest and death are primarily secondary to the neurological sequelae of coma and refractory seizures&#x000a0;and are treated with IV pyridoxine in addition to benzodiazepines and barbiturates. Admissions observing&#x000a0;for delayed pulmonary edema is reasonable as it may occur up to 24&#x000a0;to 48 hours after&#x000a0;inhalational exposure.</p>
      </sec>
      <sec id="article-147447.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>For the best outcomes for patients with&#x000a0;hydrazine toxicity, interprofessional team coordination and management are essential. First responders should be aware of the potential danger of hydrazine if exposed, and appropriate decontamination and personal protective equipment&#x000a0;should be performed.</p>
        <p>Upon arrival at the emergency department, clinicians should fully decontaminate the patient if not already performed, and consult their local poison control center to discuss management with a medical toxicologist. Nursing and lab technologists should aid in obtaining laboratory workup that aids in diagnosis and prognosis. Interprofessional care coordination with open communication is crucial to successful outcomes in hydrazine toxicity cases. [Level 5]</p>
      </sec>
      <sec id="article-147447.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=147447&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=147447">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/hydrazine-toxicology/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=147447">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/147447/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=147447">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-147447.s18">
        <title>References</title>
        <ref id="article-147447.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <article-title>Metabolic sites of hydrazine toxicity.</article-title>
            <source>Nutr Rev</source>
            <year>1968</year>
            <month>Feb</month>
            <volume>26</volume>
            <issue>2</issue>
            <fpage>56</fpage>
            <page-range>56-8</page-range>
            <pub-id pub-id-type="pmid">4867319</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <article-title>Hydrazine.</article-title>
            <source>IARC Monogr Eval Carcinog Risks Hum</source>
            <year>1999</year>
            <volume>71 Pt 3</volume>
            <issue>PT 3</issue>
            <fpage>991</fpage>
            <page-range>991-1013</page-range>
            <pub-id pub-id-type="pmid">10476371</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Choudhary</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Human health perspective on environmental exposure to hydrazines: a review.</article-title>
            <source>Chemosphere</source>
            <year>1998</year>
            <month>Aug</month>
            <volume>37</volume>
            <issue>5</issue>
            <fpage>801</fpage>
            <page-range>801-43</page-range>
            <pub-id pub-id-type="pmid">9717244</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Binyamin</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Frenkel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brotfain</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Koyfman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Shliom</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Elevated CPK levels after hydrazine inhalation exposure in an F16 aircraft technician.</article-title>
            <source>Toxicol Rep</source>
            <year>2018</year>
            <volume>5</volume>
            <fpage>927</fpage>
            <page-range>927-928</page-range>
            <pub-id pub-id-type="pmid">30225198</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Erwin</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Addison</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>John</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Olaleye</surname>
                <given-names>OA</given-names>
              </name>
              <name>
                <surname>Rosell</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Pharmacokinetics of isoniazid: The good, the bad, and the alternatives.</article-title>
            <source>Tuberculosis (Edinb)</source>
            <year>2019</year>
            <month>May</month>
            <volume>116S</volume>
            <fpage>S66</fpage>
            <page-range>S66-S70</page-range>
            <pub-id pub-id-type="pmid">31076322</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cook</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Glenn</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Podolak</surname>
                <given-names>GE</given-names>
              </name>
            </person-group>
            <article-title>Monitoring and analysis of personnel exposures to hydrazines at a rocket propellant plant.</article-title>
            <source>Am Ind Hyg Assoc J</source>
            <year>1979</year>
            <month>Jan</month>
            <volume>40</volume>
            <issue>1</issue>
            <fpage>69</fpage>
            <page-range>69-74</page-range>
            <pub-id pub-id-type="pmid">484453</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Back</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Carter</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Occupational hazards of missile operations with special regard to the hydrazine propellants.</article-title>
            <source>Aviat Space Environ Med</source>
            <year>1978</year>
            <month>Apr</month>
            <volume>49</volume>
            <issue>4</issue>
            <fpage>591</fpage>
            <page-range>591-8</page-range>
            <pub-id pub-id-type="pmid">346014</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spencer</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Kisby</surname>
                <given-names>GE</given-names>
              </name>
            </person-group>
            <article-title>Role of Hydrazine-Related Chemicals in Cancer and Neurodegenerative Disease.</article-title>
            <source>Chem Res Toxicol</source>
            <year>2021</year>
            <month>Sep</month>
            <day>20</day>
            <volume>34</volume>
            <issue>9</issue>
            <fpage>1953</fpage>
            <page-range>1953-1969</page-range>
            <pub-id pub-id-type="pmid">34379394</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McAdam</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kimpton</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Essen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vas</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Porter</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rodu</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Analysis of hydrazine in smokeless tobacco products by gas chromatography-mass spectrometry.</article-title>
            <source>Chem Cent J</source>
            <year>2015</year>
            <volume>9</volume>
            <fpage>13</fpage>
            <pub-id pub-id-type="pmid">25780382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>FRIERSON</surname>
                <given-names>WB</given-names>
              </name>
            </person-group>
            <article-title>USE OF PYRIDOXINE HCL IN ACUTE HYDRAZINE AND UDMH INTOXICATION.</article-title>
            <source>Ind Med Surg</source>
            <year>1965</year>
            <month>Aug</month>
            <volume>34</volume>
            <fpage>650</fpage>
            <page-range>650-1</page-range>
            <pub-id pub-id-type="pmid">14334180</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reid</surname>
                <given-names>FJ</given-names>
              </name>
            </person-group>
            <article-title>Hydrazine poisoning.</article-title>
            <source>Br Med J</source>
            <year>1965</year>
            <month>Nov</month>
            <day>20</day>
            <volume>2</volume>
            <issue>5472</issue>
            <fpage>1246</fpage>
            <pub-id pub-id-type="pmid">5849139</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sotaniemi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hirvonen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Isom&#x000e4;ki</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Takkunen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kaila</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Hydrazine toxicity in the human. Report of a fatal case.</article-title>
            <source>Ann Clin Res</source>
            <year>1971</year>
            <month>Feb</month>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>30</fpage>
            <page-range>30-3</page-range>
            <pub-id pub-id-type="pmid">5546553</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kirklin</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Watson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bondoc</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Burke</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Treatment of hydrazine-induced coma with pyridoxine.</article-title>
            <source>N Engl J Med</source>
            <year>1976</year>
            <month>Apr</month>
            <day>22</day>
            <volume>294</volume>
            <issue>17</issue>
            <fpage>938</fpage>
            <page-range>938-9</page-range>
            <pub-id pub-id-type="pmid">815813</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harati</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Niakan</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Hydrazine toxicity, pyridoxine therapy, and peripheral neuropathy.</article-title>
            <source>Ann Intern Med</source>
            <year>1986</year>
            <month>May</month>
            <volume>104</volume>
            <issue>5</issue>
            <fpage>728</fpage>
            <page-range>728-9</page-range>
            <pub-id pub-id-type="pmid">3008620</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dhennin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vesin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Feauveaux</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Burns and the toxic effects of a derivative of hydrazine.</article-title>
            <source>Burns Incl Therm Inj</source>
            <year>1988</year>
            <month>Apr</month>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>130</fpage>
            <page-range>130-4</page-range>
            <pub-id pub-id-type="pmid">3292016</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kao</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Chong</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Hydrazine inhalation hepatotoxicity.</article-title>
            <source>Occup Med (Lond)</source>
            <year>2007</year>
            <month>Oct</month>
            <volume>57</volume>
            <issue>7</issue>
            <fpage>535</fpage>
            <page-range>535-7</page-range>
            <pub-id pub-id-type="pmid">17761725</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wrangsj&#x000f6;</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>M&#x000e5;rtensson</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Hydrazine contact dermatitis from gold plating.</article-title>
            <source>Contact Dermatitis</source>
            <year>1986</year>
            <month>Oct</month>
            <volume>15</volume>
            <issue>4</issue>
            <fpage>244</fpage>
            <page-range>244-5</page-range>
            <pub-id pub-id-type="pmid">2948762</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suzuki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ohkido</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Contact dermatitis from hydrazine derivatives.</article-title>
            <source>Contact Dermatitis</source>
            <year>1979</year>
            <month>Mar</month>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>113</fpage>
            <page-range>113-4</page-range>
            <pub-id pub-id-type="pmid">157249</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aigner</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Darsow</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Grosber</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ring</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pl&#x000f6;tz</surname>
                <given-names>SG</given-names>
              </name>
            </person-group>
            <article-title>Multiple basal cell carcinomas after long-term exposure to hydrazine: case report and review of the literature.</article-title>
            <source>Dermatology</source>
            <year>2010</year>
            <volume>221</volume>
            <issue>4</issue>
            <fpage>300</fpage>
            <page-range>300-2</page-range>
            <pub-id pub-id-type="pmid">21099194</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r20">
          <label>20</label>
          <element-citation publication-type="book">
            <collab>IARC Working Group on the Evaluation of Carcinogenic Risks to Humans</collab>
            <source>Some Industrial Chemicals</source>
            <publisher-name>International Agency for Research on Cancer</publisher-name>
            <publisher-loc>Lyon (FR)</publisher-loc>
            <year>2018</year>
            <pub-id pub-id-type="pmid">29863829</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cammarano</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Crosignani</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Berrino</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Berra</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Cancer mortality among workers in a thermoelectric power plant.</article-title>
            <source>Scand J Work Environ Health</source>
            <year>1984</year>
            <month>Aug</month>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>259</fpage>
            <page-range>259-61</page-range>
            <pub-id pub-id-type="pmid">6494846</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ritz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Krishnadasan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Morgenstern</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Estimated effects of hydrazine exposure on cancer incidence and mortality in aerospace workers.</article-title>
            <source>Epidemiology</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>154</fpage>
            <page-range>154-61</page-range>
            <pub-id pub-id-type="pmid">16477255</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krishnadasan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Morgenstern</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ritz</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Nested case-control study of occupational chemical exposures and prostate cancer in aerospace and radiation workers.</article-title>
            <source>Am J Ind Med</source>
            <year>2007</year>
            <month>May</month>
            <volume>50</volume>
            <issue>5</issue>
            <fpage>383</fpage>
            <page-range>383-90</page-range>
            <pub-id pub-id-type="pmid">17407146</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wald</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Boreham</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Doll</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bonsall</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Occupational exposure to hydrazine and subsequent risk of cancer.</article-title>
            <source>Br J Ind Med</source>
            <year>1984</year>
            <month>Feb</month>
            <volume>41</volume>
            <issue>1</issue>
            <fpage>31</fpage>
            <page-range>31-4</page-range>
            <pub-id pub-id-type="pmid">6691933</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roe</surname>
                <given-names>FJ</given-names>
              </name>
            </person-group>
            <article-title>Hydrazine.</article-title>
            <source>Ann Occup Hyg</source>
            <year>1978</year>
            <month>Dec</month>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>323</fpage>
            <page-range>323-6</page-range>
            <pub-id pub-id-type="pmid">751560</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r26">
          <label>26</label>
          <element-citation publication-type="book">
            <collab>National Research Council (US) Committee on Acute Exposure Guideline Levels</collab>
            <source>Acute Exposure Guideline Levels for Selected Airborne Chemicals: Volume 8</source>
            <publisher-name>National Academies Press (US)</publisher-name>
            <publisher-loc>Washington (DC)</publisher-loc>
            <year>2010</year>
            <pub-id pub-id-type="pmid">25032364</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morris</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Densem</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Wald</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Doll</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Occupational exposure to hydrazine and subsequent risk of cancer.</article-title>
            <source>Occup Environ Med</source>
            <year>1995</year>
            <month>Jan</month>
            <volume>52</volume>
            <issue>1</issue>
            <fpage>43</fpage>
            <page-range>43-5</page-range>
            <pub-id pub-id-type="pmid">7697139</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Krishnadasan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Morgenstern</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ritz</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Estimated effects of solvents and mineral oils on cancer incidence and mortality in a cohort of aerospace workers.</article-title>
            <source>Am J Ind Med</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>48</volume>
            <issue>4</issue>
            <fpage>249</fpage>
            <page-range>249-58</page-range>
            <pub-id pub-id-type="pmid">16167347</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nguyen</surname>
                <given-names>HN</given-names>
              </name>
              <name>
                <surname>Chenoweth</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Bebarta</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Albertson</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Nowadly</surname>
                <given-names>CD</given-names>
              </name>
            </person-group>
            <article-title>The Toxicity, Pathophysiology, and Treatment of Acute Hydrazine Propellant Exposure: A Systematic Review.</article-title>
            <source>Mil Med</source>
            <year>2021</year>
            <month>Feb</month>
            <day>26</day>
            <volume>186</volume>
            <issue>3-4</issue>
            <fpage>e319</fpage>
            <page-range>e319-e326</page-range>
            <pub-id pub-id-type="pmid">33175959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Richter</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Gal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bitchatchi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Reches</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Residual neurobehavioral impairment in a water technician exposed to hydrazine-containing mixtures.</article-title>
            <source>Isr J Med Sci</source>
            <year>1992</year>
            <season>Aug-Sep</season>
            <volume>28</volume>
            <issue>8-9</issue>
            <fpage>598</fpage>
            <page-range>598-602</page-range>
            <pub-id pub-id-type="pmid">1428814</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>EVANS</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Two cases of hydrazine hydrate dermatitis without systemic intoxication.</article-title>
            <source>Br J Ind Med</source>
            <year>1959</year>
            <month>Apr</month>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>126</fpage>
            <page-range>126-7</page-range>
            <pub-id pub-id-type="pmid">13651555</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Makarovsky</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Markel</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dushnitsky</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Eisenkraft</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Hydrazine--the space era agent.</article-title>
            <source>Isr Med Assoc J</source>
            <year>2008</year>
            <month>Apr</month>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>302</fpage>
            <page-range>302-6</page-range>
            <pub-id pub-id-type="pmid">18548987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blair</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Mansilla Tinoco</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Brodie</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Clare</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Dollery</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Timbrell</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Beever</surname>
                <given-names>IA</given-names>
              </name>
            </person-group>
            <article-title>Plasma hydrazine concentrations in man after isoniazid and hydralazine administration.</article-title>
            <source>Hum Toxicol</source>
            <year>1985</year>
            <month>Mar</month>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>195</fpage>
            <page-range>195-202</page-range>
            <pub-id pub-id-type="pmid">4007883</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nicholls</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lindon</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Shockcor</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Farrant</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Haselden</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Damment</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Waterfield</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Nicholson</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Metabonomic investigations into hydrazine toxicity in the rat.</article-title>
            <source>Chem Res Toxicol</source>
            <year>2001</year>
            <month>Aug</month>
            <volume>14</volume>
            <issue>8</issue>
            <fpage>975</fpage>
            <page-range>975-87</page-range>
            <pub-id pub-id-type="pmid">11511171</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murray</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Goldfrank's Toxicologic Emergencies, 7th edition.</article-title>
            <source>Emerg Med Australas</source>
            <year>2004</year>
            <month>Feb</month>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>87</fpage>
            <pub-id pub-id-type="pmid">15239763</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Preece</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Ghatineh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Timbrell</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Studies on the disposition and metabolism of hydrazine in rats in vivo.</article-title>
            <source>Hum Exp Toxicol</source>
            <year>1992</year>
            <month>Mar</month>
            <volume>11</volume>
            <issue>2</issue>
            <fpage>121</fpage>
            <page-range>121-7</page-range>
            <pub-id pub-id-type="pmid">1349218</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaneo</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Iguchi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kubo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Iwagiri</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Matsuyama</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Tissue distribution of hydrazine and its metabolites in rats.</article-title>
            <source>J Pharmacobiodyn</source>
            <year>1984</year>
            <month>Aug</month>
            <volume>7</volume>
            <issue>8</issue>
            <fpage>556</fpage>
            <page-range>556-62</page-range>
            <pub-id pub-id-type="pmid">6512678</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Absorption of unsymmetrical dimethylhydrazine (UDMH) through canine skin.</article-title>
            <source>Toxicol Appl Pharmacol</source>
            <year>1971</year>
            <month>Mar</month>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>649</fpage>
            <page-range>649-59</page-range>
            <pub-id pub-id-type="pmid">5569836</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>The absorption of monomethylhydrazine through canine skin.</article-title>
            <source>Proc Soc Exp Biol Med</source>
            <year>1969</year>
            <month>May</month>
            <volume>131</volume>
            <issue>1</issue>
            <fpage>226</fpage>
            <page-range>226-32</page-range>
            <pub-id pub-id-type="pmid">5770107</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <article-title>Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide.</article-title>
            <source>IARC Monogr Eval Carcinog Risks Hum</source>
            <year>1999</year>
            <volume>71 Pt 1, Pt 2, Pt 3</volume>
            <issue>PT 1</issue>
            <fpage>1</fpage>
            <page-range>1-1554</page-range>
            <pub-id pub-id-type="pmid">10507919</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Noda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Noda</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Misaka</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sumimoto</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tatsumi</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Hydrazine radical formation catalyzed by rat microsomal NADPH-cytochrome P-450 reductase.</article-title>
            <source>Biochem Biophys Res Commun</source>
            <year>1988</year>
            <month>May</month>
            <day>31</day>
            <volume>153</volume>
            <issue>1</issue>
            <fpage>256</fpage>
            <page-range>256-60</page-range>
            <pub-id pub-id-type="pmid">2837203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>FROST</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>HJORTH</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Contact dermatitis from hydrazine hydrochloride in soldering flux; cross sensitization to apresoline and isoniazid.</article-title>
            <source>Acta Derm Venereol</source>
            <year>1959</year>
            <volume>39</volume>
            <fpage>82</fpage>
            <page-range>82-6</page-range>
            <pub-id pub-id-type="pmid">13825413</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hovding</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Occupational dermatitis from hydrazine hydrate used in boiler protection. Cross sensitization to apresoline, isoniazid and phenelzine.</article-title>
            <source>Acta Derm Venereol</source>
            <year>1967</year>
            <volume>47</volume>
            <issue>5</issue>
            <fpage>293</fpage>
            <page-range>293-7</page-range>
            <pub-id pub-id-type="pmid">4168785</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Petersen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bredahl</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lauritsen</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Laursen</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Examination of the liver in personnel working with liquid rocket propellant.</article-title>
            <source>Br J Ind Med</source>
            <year>1970</year>
            <month>Apr</month>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>141</fpage>
            <page-range>141-6</page-range>
            <pub-id pub-id-type="pmid">5428632</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hainer</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Komura</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Chiu</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Fatal hepatorenal failure associated with hydrazine sulfate.</article-title>
            <source>Ann Intern Med</source>
            <year>2000</year>
            <month>Dec</month>
            <day>05</day>
            <volume>133</volume>
            <issue>11</issue>
            <fpage>877</fpage>
            <page-range>877-80</page-range>
            <pub-id pub-id-type="pmid">11103057</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crain</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Gershel</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Mezey</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>Caustic ingestions. Symptoms as predictors of esophageal injury.</article-title>
            <source>Am J Dis Child</source>
            <year>1984</year>
            <month>Sep</month>
            <volume>138</volume>
            <issue>9</issue>
            <fpage>863</fpage>
            <page-range>863-5</page-range>
            <pub-id pub-id-type="pmid">6475876</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sinha</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Mason</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>BIOTRANSFORMATION OF HYDRAZINE DERVATIVES IN THE MECHANISM OF TOXICITY.</article-title>
            <source>J Drug Metab Toxicol</source>
            <year>2014</year>
            <volume>5</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">31171988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steinhoff</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mohr</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>WM</given-names>
              </name>
            </person-group>
            <article-title>On the question of the carcinogenic action of hydrazine--evaluation on the basis of new experimental results.</article-title>
            <source>Exp Pathol</source>
            <year>1990</year>
            <volume>39</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-9</page-range>
            <pub-id pub-id-type="pmid">2394235</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Toth</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>A review of the antineoplastic action of certain hydrazines and hydrazine-containing natural products.</article-title>
            <source>In Vivo</source>
            <year>1996</year>
            <season>Jan-Feb</season>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>65</fpage>
            <page-range>65-96</page-range>
            <pub-id pub-id-type="pmid">8726813</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Minns</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Ghafouri</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>Isoniazid-induced status epilepticus in a pediatric patient after inadequate pyridoxine therapy.</article-title>
            <source>Pediatr Emerg Care</source>
            <year>2010</year>
            <month>May</month>
            <volume>26</volume>
            <issue>5</issue>
            <fpage>380</fpage>
            <page-range>380-1</page-range>
            <pub-id pub-id-type="pmid">20453796</pub-id>
          </element-citation>
        </ref>
        <ref id="article-147447.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nagappan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Riddell</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Pyridoxine therapy in a patient with severe hydrazine sulfate toxicity.</article-title>
            <source>Crit Care Med</source>
            <year>2000</year>
            <month>Jun</month>
            <volume>28</volume>
            <issue>6</issue>
            <fpage>2116</fpage>
            <page-range>2116-8</page-range>
            <pub-id pub-id-type="pmid">10890675</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
